dc.creatorQueiroz Telles, Flavio
dc.creatorNucci, Marcio
dc.creatorLopes Colombo, Arnaldo
dc.creatorTobón Orozco, Ángela María
dc.creatorRestrepo Moreno, Ángela
dc.date2021-11-15T20:20:56Z
dc.date2021-11-15T20:20:56Z
dc.date2011
dc.date.accessioned2023-08-28T20:21:55Z
dc.date.available2023-08-28T20:21:55Z
dc.identifierFlavio Queiroz-Telles, Marcio Nucci, Arnaldo Lopes Colombo, Ángela Tobón, Ángela Restrepo, Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment, Medical Mycology, Volume 49, Issue 3, April 2011, Pages 225–236, https://doi.org/10.3109/13693786.2010.539631
dc.identifier1369-3786
dc.identifierhttp://hdl.handle.net/10495/24124
dc.identifier10.3109/13693786.2010.539631
dc.identifier1460-2709
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8478019
dc.descriptionABSTRACT: Implantation or subcutaneous mycoses are a frequent health problem in Latin American countries and other tropical and subtropical areas. Although such infections rarely cause disseminated or invasive disease, they have an important impact on public health, and timely diagnosis and appropriate treatment remain important. Although some implantation mycoses are found in immunocompromised persons, the immunocompetent population is the principal target in Latin America. Most etiologic agents are found in soil, vegetation, and decaying matter in tropical, subtropical, and humid environments and infection is commonly the result of penetrating injury. Infections primarily occur (1) among low socioeconomic groups, (2) among those living in rural areas or involved in farming, hunting, or other outdoor activities, and (3) particularly among adult men. This review focuses on the epidemiology of the most clinically significant implantation mycoses in Latin America, i.e., sporotrichosis, eumycetoma, chromoblastomycosis, subcutaneous phaeohyphomycosis, subcutaneous zygomycosis, and lacaziosis. Main epidemiologic findings, clinical manifestations, diagnosis, and treatment options are also discussed.
dc.descriptionCOL0013709
dc.format12
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherOxford University Press
dc.publisherMicología Médica y Experimental
dc.publisherOxford, Inglaterra
dc.relationMed. Mycol.
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licenses/by-nc/2.5/co/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectMicosis
dc.subjectMycoses
dc.subjectItraconazol
dc.subjectItraconazole
dc.subjectAmérica Latina
dc.subjectLatin America
dc.titleMycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typehttp://purl.org/coar/resource_type/c_dcae04bc
dc.typehttps://purl.org/redcol/resource_type/ARTREV
dc.typeArtículo de revisión


Este ítem pertenece a la siguiente institución